AI drug discovery is changing which experiments reach patients

From molecular design to trial recruitment, artificial intelligence is influencing the choices behind drug development. European researchers and companies must distinguish faster selection from demonstrated therapeutic benefit.

The post AI drug discovery is changing which experiments reach patients appeared first on Innovation News Network.